0001209191-21-019157.txt : 20210309
0001209191-21-019157.hdr.sgml : 20210309
20210309174008
ACCESSION NUMBER: 0001209191-21-019157
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210305
FILED AS OF DATE: 20210309
DATE AS OF CHANGE: 20210309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ho Tony W
CENTRAL INDEX KEY: 0001713637
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 21727124
MAIL ADDRESS:
STREET 1: CRISPR THERAPEUTICS AG
STREET 2: 610 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-05
0
0001674416
CRISPR Therapeutics AG
CRSP
0001713637
Ho Tony W
C/O CRISPR THERAPEUTICS, INC.
610 MAIN STREET
CAMBRIDGE
MA
02139
0
1
0
0
Executive VP, Head of R&D
Common Shares
2021-03-05
4
M
0
3333
A
37447
D
Common Shares
2021-03-05
4
F
0
1585
114.65
D
35862
D
On March 5, 2019, the reporting person was granted 10,000 restricted stock units. On March 5, 2021, 3,333 restricted stock units vested.
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
Includes 150 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan.
Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
/s/ Michael Esposito, attorney-in-fact
2021-03-09